期刊
CURRENT OPINION IN OPHTHALMOLOGY
卷 29, 期 4, 页码 361-365出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/ICU.0000000000000483
关键词
antiviral; epithelial keratitis; herpes simplex virus; resistance; vaccine
Purpose of review To review recent advancements in the management of herpes simplex virus (HSV) epithelial keratitis. Recent findings Trifluridine eye drop, acyclovir (ACV) ointment, ganciclovir gel, and oral ACV are still the main therapeutic agents. Cryopreserved amniotic membrane has been recently used as an adjuvant treatment. Resistance to ACV has become a concerning issue. The animal models of HSV vaccine are able to reduce HSV keratitis. New antivirals are under development. Summary Current cases of HSV epithelial keratitis are manageable with available medications, but new advancements are required to decrease disease burden in the future. HSV vaccine can be revolutionary.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据